ArticleOPEN ACCESS

"IM iD" eally treating multiple myeloma

Blood
DOI: 10.1182/blood-2013-01-476267
3Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Leleu and colleagues1 and Richardson and colleagues2 publish two different trials using pomalidomide and dexamethasone in patients with relapsed and refractory multiple myeloma (MM).

Cite

CITATION STYLE

APA

Lacy, M. Q. (2013). “IM iD” eally treating multiple myeloma. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2013-01-476267

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free